Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PTN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
5 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
26 filers reported a long position in PTN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC | $1.8M | 166.7K | Unchanged |
| Jupiter Topco LLC | $1.5M | 140K | — |
| Logos Global Management LP | $1.4M | 130K | -7.1% |
| RA CAPITAL MANAGEMENT, L.P. | $670.3K | 62.1K | -11.3% |
| BALYASNY ASSET MANAGEMENT L.P. | $443.6K | 41.1K | -0.1% |
| MORGAN STANLEY | $294.3K | 27.3K | Unchanged |
| Opaleye Management Inc. | $221.2K | 20.5K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $209.2K | 19.4K | +4.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | $204.1K | 18.9K | -0.4% |
| Miller Financial Services LLC | $161.9K | 15K | +19% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.